Associate Professor, Pediatric Hematology and Oncology, Baylor College of Medicine

Pediatric Hematology & Oncology

Lisa Bomgaars works in the field of Pediatric Hematology & Oncology. She attended Baylor College of Medicine. Lisa Bomgaars is a published doctor as well. She has 39 publications published. The latest was: The inactivation of doxorubicin by long ultraviolet light.

Publications

---

• Age-Based Difference in Activation Markers of Coagulation and Fibrinolysis in Extracorporeal Membrane Oxygenation.
• Response to Warfarin Therapy in Obese Pediatric Patients Dosed According to Institutional Guidelines.
• AntiCoagulation Therapy Trends in Children Supported by Ventricular Assist Devices: A Multi-Institutional Study.
• Readmissions for warfarin-related bleeding in pediatric patients after hospital discharge.
• Comparison of anti-xa levels in obese and non-obese pediatric patients receiving treatment doses of enoxaparin.
• Prospective trial of a pediatric ventricular assist device.
• Risk factors for elevated INR values during warfarin therapy in hospitalized pediatric patients.
• Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP).
• A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia.
• Development of factor V and thrombin inhibitors in children following bovine thrombin exposure during cardiac surgery: a report of three cases.
• The role of adjunctive exenatide therapy in pediatric type 1 diabetes.
• Pediatric warfarin practice and pharmacogenetic testing.
• Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia.
• Pharmacokinetics and safety of famciclovir in children with herpes simplex or varicella-zoster virus infection.
• Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study.
• Valacyclovir and acyclovir pharmacokinetics in immunocompromised children.
• Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children''s oncology group.
• Low prevalence and assay discordance of "aspirin resistance" in children.
• Folate pathway genetic polymorphisms are related to attention Disorders in childhood leukemia survivors.
• Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group Study.
• Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis.
• A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study.
• Ontogeny of dextromethorphan O- and N-demethylation in the first year of life.
• Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia.
• Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
• Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004).
• Phase I trial of irofulven (MGI 114) in pediatric patients with solid tumors.
• Pharmacogenetics and pediatric cancer.
• The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes.
• A phase I study of irinotecan administered on a weekly schedule in pediatric patients.
• Phase I and pharmacokinetic study of thalidomide with carboplatin in children with cancer.
• Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.
• Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia.
• The development of camptothecin analogs in childhood cancers.
• Pharmacokinetics and cerebrospinal fluid penetration of phenylacetate and phenylbutyrate in the nonhuman primate.
• Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.
• The inactivation of doxorubicin by long ultraviolet light.
• Lymphoid malignancies following Kawasaki disease.

Schools

---

• Ohio State University College of Medicine

• Baylor College Of Med

Conditions Treated

---

• Anemia
• Coagulation Disorders (incl. Hemophilia)
• Deep Vein Thrombosis (DVT)

Doctors Specialties

---

• Pediatric Hematology
• Oncology

Accepted Insurances

---

Education

---

• Baylor College of Medicine
• The Ohio State University College of Medicine

Hospital

---

• Texas Children's Hospital

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Chrystal U. Louis, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert Krance, MD This Doctor is OpenDoctor Recommended.
	Dr. Jack M. Su, MD This Doctor is OpenDoctor Recommended.
	Dr. Nabil M. Ahmed, MD This Doctor is OpenDoctor Recommended.
	Dr. Catherine Bollard, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Winston W. Huh, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Heidi Russell, MD This Doctor is OpenDoctor Recommended.
	Chetan A. Dhamne, MB This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog